References
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915–1919.
Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005; 11: 429–436.
Komatsu T, Narimatsu H, Yoshimi A, Kurita N, Kusakabe M, Hori A et al. Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol 2007; 86: 49–54.
Inamoto Y, Oba T, Miyamura K, Terakura S, Tsujimura A, Kuwatsuka Y et al. Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor. Int J Hematol 2006; 83: 356–362.
Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T . Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85–87.
Narimatsu H, Murata M, Sugimoto K, Terakura S, Kinoshita T, Naoe T . Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma. Leuk Lymphoma 2007; 48: 841–843.
Narimatsu H, Kami M, Miyakoshi S, Murashige N, Yuji K, Hamaki T et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006; 132: 36–41.
Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 2007; 39: 31–39.
Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y et al. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant 2007; 13: 822–830.
Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960–1969.
Acknowledgements
We are grateful to Dr Seitaro Terakura and Professor Tomoki Naoe (Nagoya University Graduate School of Medicine) for their critical reading of the paper. We thank all the staff and resident members of the participating institutions.
Author information
Authors and Affiliations
Consortia
Corresponding author
Appendix
Appendix
This study was conducted at the following institutions in NBMTG: Nagoya University Hospital, Nagoya; Fujita Health University Hospital, Toyoake; JA Aichi Showa Hospital, Konan; Japanese Red Cross Nagoya First Hospital, Nagoya; and Nagoya Daini Red Cross Hospital, Nagoya, Japan.
Rights and permissions
About this article
Cite this article
Narimatsu, H., Watanabe, M., Kohno, A. et al. High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplant 41, 753–756 (2008). https://doi.org/10.1038/sj.bmt.1705978
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705978
- Springer Nature Limited
This article is cited by
-
Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil
Annals of Hematology (2022)
-
Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation
Bone Marrow Transplantation (2017)
-
Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen
Bone Marrow Transplantation (2014)
-
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies
Bone Marrow Transplantation (2014)
-
Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin
Bone Marrow Transplantation (2013)